See All Resources
Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol
Go to Resource
Share:
Link is copied!
Originally Published:
June 01, 2016
